Big drop in pay-for-delay questions, Reeves says
iStock/okskaz
Latham & Watkins antitrust chair Amanda Reeves has said that drugmakers are seeking counselling regarding pay-for-delay significantly less often than they did in the past.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10